Mary A. Bewick - Concepedia

Author

Mary A. Bewick

Northeast Cancer Centre

Also Known As

M Bewick, M. A. Bewick, M. Bewick, Mary A Bewick, Mary A. Bewick, Mary Bewick

Publications

608

Citations

H-Index

Concepts

All Affiliations

Northeast Cancer Centre University of Calgary Sudbury Regional Hospital NOSM University Northeastern University

About

Mary A. Bewick is an author at Northeast Cancer Centre specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	250
2	Cell Biology	3	3	69
3	Immunology	2	2	80
4	Public Health	1	1	40
5	Biochemistry	1	1	38

Mary A. Bewick

Publications

539

Citations

H-Index

Page 1

	Year	Citations
The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity Rachel Syme, Mary A. Bewick, D Stewart, Biology of Blood and Marrow Transplantation	2004	124
Polymorphisms in<i>XRCC1</i>,<i>XRCC3</i>, and<i>CCND1</i>and Survival After Treatment for Metastatic Breast Cancer Mary A. Bewick, Michael Conlon, Robert M. Lafrenie Journal of Clinical Oncology	2006	77
Evaluation of three rapid RNA extraction reagents: relevance for use in RT-PCR's and measurement of low level gene expression in clinical samples. T Chadderton, Carolyn A. Wilson, Mary A. Bewick, PubMed GeneticsImmunologyBlood CellPathologyNucleic Acid Amplification Test	1997	61
Smoking (active and passive), N-acetyltransferase 2, and risk of breast cancer Michael Conlon, Kenneth C. Johnson, Mary A. Bewick, Cancer Epidemiology Tobacco ControlBreast OncologyTobacco UseMedicineNicotine	2010	40
Soluble Fas (CD95) Is a Prognostic Factor in Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplantation Mary A. Bewick, Michael Conlon, Amadeo M. Parissenti, Journal of Hematotherapy & Stem Cell Research	2001	39
Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer Mary A. Bewick, Michael Conlon, Robert M. Lafrenie Breast Cancer Research and Treatment Metastatic Breast CancerBreast OncologyBiochemistryPathologyBreast Cancer	2007	38
HER-2 expression is a prognostic factor in patients with metastatic breast cancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support Mary A. Bewick, Michael Conlon, S Gerard, Bone Marrow Transplantation Metastatic Breast CancerBreast OncologyHigh-dose CyclophosphamideMedicinePathology	2001	32
Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support Mary A. Bewick, T Chadderton, Michael Conlon, Bone Marrow Transplantation Metastatic Breast CancerOncologyBreast OncologyMedicineBreast Cancer	1999	26
Single Nucleotide Polymorphisms in CHRNA5 rs16969968, CHRNA3 rs578776, and LOC123688 rs8034191 Are Associated With Heaviness of Smoking in Women in Northeastern Ontario, Canada Michael Conlon, Mary A. Bewick Nicotine & Tobacco Research	2011	25
HSG cells differentiated by culture on extracellular matrix involves induction of S‐adenosylmethione decarboxylase and ornithine decarboxylase Kirby Lam, Zhang Lian-feng, Mary A. Bewick, Journal of Cellular Physiology	2004	24

Page 1